Consolidated Balance Sheets - USD ($)	Sep. 30, 2024		Dec. 31, 2023
Assets
Cash and due from banks	$ 124,076,000		$ 129,898,000
Interest-earning deposits	303,908,000		361,533,000
Cash and cash equivalents	427,984,000	[1]	491,431,000
Certificates of deposit in other banks	3,189,000		6,374,000
Securities available for sale (“AFS”), at fair value	825,907,000		802,573,000
Other investments	60,443,000		57,560,000
Loans held for sale	11,121,000		4,160,000
Loans	6,556,840,000		6,353,942,000
Allowance for credit losses - loans (“ACL-Loans”)	(65,785,000)		(63,610,000)
Loans, net	6,491,055,000		6,290,332,000
Premises and equipment, net	123,585,000		118,756,000
Bank owned life insurance (“BOLI”)	185,011,000		169,392,000
Goodwill and other intangibles, net	389,727,000		394,366,000
Accrued interest receivable and other assets	119,096,000		133,734,000
Total assets	8,637,118,000		8,468,678,000
Liabilities:
Noninterest-bearing demand deposits	1,839,617,000		1,958,709,000
Interest-bearing deposits	5,420,380,000		5,239,091,000
Total deposits	7,259,997,000		7,197,800,000
Short-term borrowings	0		0
Long-term borrowings	161,210,000		166,930,000
Accrued interest payable and other liabilities	66,584,000		64,941,000
Total liabilities	7,487,791,000		7,429,671,000
Stockholders’ Equity:
Common stock	151,000		149,000
Additional paid-in capital	647,934,000		633,770,000
Retained earnings	535,638,000		458,261,000
Accumulated other comprehensive income (loss)	(34,396,000)		(53,173,000)
Total stockholders’ equity	1,149,327,000		1,039,007,000
Total liabilities and stockholders’ equity	$ 8,637,118,000		$ 8,468,678,000
Preferred shares authorized (no par value)	10,000,000		10,000,000
Preferred shares issued and outstanding	0		0
Common shares authorized (par value $0.01 per share)	30,000,000		30,000,000
Common shares outstanding	15,104,381		14,894,209
Common shares issued	15,158,639		14,951,367

[1] There was no restricted cash in cash and cash equivalents at either September 30, 2024 or September 30, 2023.